You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 11, Issue 12

December 2019 - 223 articles

Cover Story: Despite being an extremely inefficient process, the high burden of lethality in metastatic prostate cancer patients can be attributed to a plethora of strategies utilized by the cancer cells that have escaped the primary tumor. Striking similarities exist between the means used to achieve metastasis and military combat, where oftentimes, the modus operandi involves the creative use of tactics to overcome the host systems. These strategies include priming the metastatic sites ahead of colonization, targeting specific organs, outsmarting the host immune surveillance, lying in a dormant state at the metastatic site for prolonged periods, and widespread reprogramming of gene expression. This review provides a perspective for understanding metastasis from the standpoint of military combat, wherein strategic maneuvering instead of brute force often plays a decisive role in the outcome. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (223)

  • Article
  • Open Access
41 Citations
5,375 Views
20 Pages

Gigantol Targets Cancer Stem Cells and Destabilizes Tumors via the Suppression of the PI3K/AKT and JAK/STAT Pathways in Ectopic Lung Cancer Xenografts

  • Nattanan Losuwannarak,
  • Arnatchai Maiuthed,
  • Nakarin Kitkumthorn,
  • Asada Leelahavanichkul,
  • Sittiruk Roytrakul and
  • Pithi Chanvorachote

17 December 2019

Lung cancer has long been recognized as an important world heath concern due to its high incidence and death rate. The failure of treatment strategies, as well as the regrowth of the disease driven by cancer stem cells (CSCs) residing in the tumor, l...

  • Article
  • Open Access
30 Citations
4,438 Views
11 Pages

Clinicopathologic and Imaging Features of Non-Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations

  • Subba R. Digumarthy,
  • Dexter P. Mendoza,
  • Eric W. Zhang,
  • Jochen K. Lennerz and
  • Rebecca S. Heist

17 December 2019

MET exon 14 (METex14) skipping mutations are an emerging potentially targetable oncogenic driver mutation in non-small-cell lung cancer (NSCLC). The imaging features and patterns of metastasis of NSCLC with primary METex14 skipping mutations (METex14...

  • Review
  • Open Access
4 Citations
5,652 Views
16 Pages

Companion Animals as Models for Inhibition of STAT3 and STAT5

  • Matthias Kieslinger,
  • Alexander Swoboda,
  • Nina Kramer,
  • Barbara Pratscher,
  • Birgitt Wolfesberger and
  • Iwan A. Burgener

17 December 2019

The use of transgenic mouse models has revolutionized the study of many human diseases. However, murine models are limited in their representation of spontaneously arising tumors and often lack key clinical signs and pathological changes. Thus, a clo...

  • Article
  • Open Access
48 Citations
6,171 Views
18 Pages

Nanosecond Pulsed Electric Fields Induce Endoplasmic Reticulum Stress Accompanied by Immunogenic Cell Death in Murine Models of Lymphoma and Colorectal Cancer

  • Alessandra Rossi,
  • Olga N. Pakhomova,
  • Peter A. Mollica,
  • Maura Casciola,
  • Uma Mangalanathan,
  • Andrei G. Pakhomov and
  • Claudia Muratori

17 December 2019

Depending on the initiating stimulus, cancer cell death can be immunogenic or non-immunogenic. Inducers of immunogenic cell death (ICD) rely on endoplasmic reticulum (ER) stress for the trafficking of danger signals such as calreticulin (CRT) and ATP...

  • Article
  • Open Access
4 Citations
3,558 Views
13 Pages

Pathways, Processes, and Candidate Drugs Associated with a Hoxa Cluster-Dependency Model of Leukemia

  • Laura M. Kettyle,
  • Charles-Étienne Lebert-Ghali,
  • Ivan V. Grishagin,
  • Glenda J. Dickson,
  • Paul G. O’Reilly,
  • David A. Simpson,
  • Janet J. Bijl,
  • Ken I. Mills,
  • Guy Sauvageau and
  • Alexander Thompson

17 December 2019

High expression of the HOXA cluster correlates with poor clinical outcome in acute myeloid leukemias, particularly those harboring rearrangements of the mixed-lineage-leukemia gene (MLLr). Whilst decreased HOXA expression acts as a readout for candid...

  • Review
  • Open Access
53 Citations
9,560 Views
18 Pages

Pain Management in Patients with Multiple Myeloma: An Update

  • Flaminia Coluzzi,
  • Roman Rolke and
  • Sebastiano Mercadante

17 December 2019

Most patients with multiple myeloma (MM) suffer from chronic pain at every stage of the natural disease process. This review focuses on the most common causes of chronic pain in MM patients: (1) pain from myeloma bone disease (MBD); (2) chemotherapy-...

  • Article
  • Open Access
13 Citations
4,286 Views
18 Pages

GSTO1*CC Genotype (rs4925) Predicts Shorter Survival in Clear Cell Renal Cell Carcinoma Male Patients

  • Tanja Radic,
  • Vesna Coric,
  • Zoran Bukumiric,
  • Marija Pljesa-Ercegovac,
  • Tatjana Djukic,
  • Natasa Avramovic,
  • Marija Matic,
  • Smiljana Mihailovic,
  • Dejan Dragicevic and
  • Zoran Dzamic
  • + 2 authors

17 December 2019

Omega class glutathione transferases, GSTO1-1 and GSTO2-2, exhibit different activities involved in regulation of inflammation, apoptosis and redox homeostasis. We investigated the the prognostic significance of GSTO1 (rs4925) and GSTO2 (rs156697 and...

  • Article
  • Open Access
29 Citations
4,916 Views
18 Pages

Simultaneous Multi-Organ Metastases from Chemo-Resistant Triple-Negative Breast Cancer Are Prevented by Interfering with WNT-Signaling

  • Iram Fatima,
  • Ikbale El-Ayachi,
  • Hilaire C. Playa,
  • Jackelyn A. Alva-Ornelas,
  • Aysha B. Khalid,
  • William L. Kuenzinger,
  • Peter Wend,
  • Jackelyn C. Pence,
  • Lauren Brakefield and
  • Raisa I. Krutilina
  • + 6 authors

17 December 2019

Triple-negative breast cancers (TNBCs), which lack specific targeted therapy options, evolve into highly chemo-resistant tumors that metastasize to multiple organs simultaneously. We have previously shown that TNBCs maintain an activated WNT10B-drive...

  • Article
  • Open Access
28 Citations
4,672 Views
22 Pages

Magnetic Silica-Coated Iron Oxide Nanochains as Photothermal Agents, Disrupting the Extracellular Matrix, and Eradicating Cancer Cells

  • Jelena Kolosnjaj-Tabi,
  • Slavko Kralj,
  • Elena Griseti,
  • Sebastjan Nemec,
  • Claire Wilhelm,
  • Anouchka Plan Sangnier,
  • Elisabeth Bellard,
  • Isabelle Fourquaux,
  • Muriel Golzio and
  • Marie-Pierre Rols

17 December 2019

Cancerous cells and the tumor microenvironment are among key elements involved in cancer development, progression, and resistance to treatment. In order to tackle the cells and the extracellular matrix, we herein propose the use of a class of silica-...

  • Article
  • Open Access
47 Citations
16,593 Views
17 Pages

The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer

  • Rosalba Florio,
  • Serena Veschi,
  • Viviana di Giacomo,
  • Sara Pagotto,
  • Simone Carradori,
  • Fabio Verginelli,
  • Roberto Cirilli,
  • Adriano Casulli,
  • Antonino Grassadonia and
  • Nicola Tinari
  • + 4 authors

17 December 2019

Pancreatic cancer (PC) is one of the most lethal, chemoresistant malignancies and it is of paramount importance to find more effective therapeutic agents. Repurposing of non-anticancer drugs may expand the repertoire of effective molecules. Studies o...

of 23

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694Creative Common CC BY license